Table 4.
Full Sample (N=80) |
Low-Frequency Users (n=41) |
High-Frequency Users (n=39) |
||||
---|---|---|---|---|---|---|
ΔR2 | β | ΔR2 | β | ΔR2 | β | |
Step 1 | .30** | .01 | .13† | |||
fMRI protocol | .02 | .04 | −.01 | |||
Drug dependence symptoms at baseline | .54** | −.07** | .36* | |||
Step 2 | .05** | .02 | .10† | |||
Substance use group | .23 | |||||
Medial prefrontal cortex activation | −.22‡ | −.02 | .39* | |||
Left angular gyrus activation | .17 | .18 | .13 | |||
Step 3 | .02** | |||||
Use group × medial prefrontal interaction | −.49 | |||||
Use group × left angular gyrus interaction | −.07 |
p < .01
p < .05
p = .05
p = .07